General Policy

Zentime adheres to the highest standards concerning its editorial policies on publication ethics, scientific misconduct, consent and peer review criteria. Zentime journals follow the guidance enacted by bodies of the Committee on Publication Ethics, the World Association of Medical Editors (WAME; www.wame.org) and the International Committee of Medical Journal Editors (ICMJE; www.icmje.org).

All submitted manuscripts shouldn' t have been published elsewhere (except in the form of an abstract or as part of a published lecture or thesis) and are not currently under consideration for publication by another journal. The corresponding author(s) should ensure that all authors have contributed to the design or conduction of the study, read and approved the final manuscript for submission. The authors should keep a copy of the manuscript in case of loss or damage. Accepted manuscripts may be subject to editorial revision without notice. The contents of the published manuscripts are available online at the official journal website under the open access policy.

At any time, once a manuscript is submitted for review and possible publication in Zentime, the editor will evaluate the contents of manuscript, which is absolutely not treated with prejudice on race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the author(s).

The editor and any editorial staff do not disclose any information about a submitted manuscript to anyone other than the reviewers, potential reviewers and other editorial advisers. Unpublished materials disclosed in a submitted manuscript will be never used in any editor's research without the written consent of the author(s).

Peer Review Policy

All manuscripts are subjected to peer review and are expected to meet the rigorous standards of academic excellence. The authors should provide 3 potential peer reviewers, who have expertise in their field of study and will be able to provide objective comments regarding the manuscript, with detailed contact information including e-mail address. If not provided, potential reviewers will be identified by their publication record or recommended by the Editorial Board members. Recommended reviewers who have been a co-author with the corresponding author will not be assigned. Reviewers recommended by authors will be only considered when other appropriate ones are not available.

As a policy, any manuscript received for review is treated as confidential documents. They are never shown to or discussed with others except those authorized by the editor. The review process is conducted objectively, and personal criticism of the author(s) is inappropriate. All reviewers should express their comments clearly with supporting arguments.

Editorial Board Policy

The Editorial Board oversees the peer review process for the journal, e.g., evaluating submissions, selecting reviewers and assessing their comments, and making editorial decisions. The Board are involved in the development of journal policies, ethics standards, and work to promote Zentime's mission to provide a great forum for academic exchange.

Our Editorial Board Members enjoy the benefits of submitting two manuscripts each year with publishing fee waived and are expected to review a minimum of 2 articles in their field of expertise. All Editorial Board members are expected to develop and make a great contribution to the Open Access publication community where possible and appropriate.

Open Access Policy

All content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. 

Plagiarism Policy

The practice of using or copying someone else's work, and reusing without proper citations to the creator or without copyright permissions obtained is regarded as plagiarism.

All submitted manuscripts will be evaluated using plagiarism detection software. If having a high repetition rate with previously published articles after preliminary review, the article will be rejected within 7 days after submission generally.

PRINCIPLES of TRANSPARENCY

Ownership and management

ZENTIME PUBLISHING CORPORATION LIMITED is created by Siting Jiang on July 30, 2021. We believe in Endless possibilities in academia.

Key Management Staff:

Emma Greene, General Manager, US

Vivian Wei, Consulting Editor Manager, China

Suki Xiao, Production Manager, China

Paul Mccleary, Technical Manager, France

Housel Wiler, Hand of Ethical Review Team, Germany

Wendy Pang, Marketing Manager, China

Jay Priede, Marketing Manager, UK

Lena Mehn, Marketing Manager, UK

Lisa Bao, Financial Manager, China

The type of identity transparency: Single anonymized.

The reviewer's identity is not visible to the author, while the author's identity is visible to the reviewer. Both the reviewer and author identities are visible to the decision-making editor.

Publishing schedule

ZENTIME is an open access publisher. All accepted papers are published regualrly after completion of the manuscript production process and made freely available on the journal's website immediately upon publication. Authors receive finalized PDFs of their papers.

Publication Ethics Statement & Copyright and Licensing

Please click here to check the details. 

BUSINESS PRACTICES

Author fees

Please note no publication fees will be charged until 2026. The submission of a manuscript, the peer-review process and proofreading are all free of charge.

Revenue sources

ZENTIME is a for-profit open access publisher that does not receive funding from government, educational, charitable, or other sources, nor does it carry paid advertisements. Our income is derived from article-processing charges and platform fees for those who want individualized “manuscript submission and review system” services or need editorial services.

Direct marketing

As a responsible publisher, ZENTIME adheres to global anti-spam laws and will only consider cooperating with reputable medical list companies that provide fully opted-in lists.

Advertising

ZENTIME does not accept paid advertising in any of its publications, including journal articles and the website.